Brian R. Vuillemenot

An anti-CD3/anti–CLL-1 bispecific antibody for the treatment of acute myeloid leukemia

Steven R. Leong, Siddharth Sukumaran, Maria Hristopoulos et al. · Blood · 2016 · 153 citations · Full text

Medicine, Hematology, Oncology +14

Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration

Ruslan N. Grishanin, Brian R. Vuillemenot, Pallavi Sharma et al. · Molecular Therapy · 2018 · 130 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Aberrant Promoter Hypermethylation of the <b> <i>Death-Associated Protein Kinase</i> </b> Gene Is Early and Frequent in Murine Lung Tumors Induced by Cigarette Smoke and Tobacco Carcinogens

Leah C. Pulling, Brian R. Vuillemenot, Julie A. Hutt et al. · Cancer Research · 2004 · 106 citations

Medicine, Molecular Biology, Oncology +17

Enzyme replacement therapy attenuates disease progression in a canine model of late‐infantile neuronal ceroid lipofuscinosis (<scp>CLN</scp>2 disease)

Martin L. Katz, Joan R. Coates, Christine M. Sibigtroth et al. · Journal of Neuroscience Research · 2014 · 100 citations · Full text

Medicine, Neurobiology, Neurology +13

Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways

Julie A. Hutt, Brian R. Vuillemenot, Edward B. Barr et al. · Carcinogenesis · 2005 · 91 citations

Pharmacy, Toxicology, Cancer Epidemiology +12